Per Agvald

Per Agvald is an accomplished medical professional and researcher currently serving as VD at Attgeno AB since February 2015, leveraging expertise gained from a research background at Karolinska Institutet, particularly in the study of nitric oxide (NO) and its functions in the human body. In addition, Per holds the position of Överläkare at Region Stockholm since January 2011, where responsibilities include medical leadership at the Mottagning för Tvångssyndrom, which was co-founded in 2015. Per's academic journey includes earning a Medicine Doctor degree from Karolinska Institutet from 1997 to 2003 and completing the läjkarlinjen program from 1990 to 2002, alongside earlier education at Kristofferskolan from 1978 to 1990.